腾讯持股近20%的卓正医疗三度递表登录港交所，暗盘一度大涨105%，每手最高赚3150港元

Core Viewpoint - Cheuk Sing Ho, a private mid-to-high-end comprehensive medical service provider, is set to list on the Hong Kong Stock Exchange on February 6, 2025, after multiple previous attempts [1][5]. Group 1: IPO Details - The company has appointed Haitong International and Ping An International as joint sponsors for its IPO [1]. - The latest trading data from Futu Securities indicates a price of HKD 98.8, representing a 64.94% increase from the offering price of HKD 59.9, with a market capitalization of HKD 63.61 billion [1][2]. Group 2: Financial Performance - Cheuk Sing Ho's revenue for 2022, 2023, and 2024 is projected to be RMB 473.2 million, RMB 690.4 million, and RMB 958.6 million, respectively, reflecting a compound annual growth rate (CAGR) of 42.3% [5][6]. - The company reported operating losses of RMB 137.6 million in 2022, RMB 66.9 million in 2023, and RMB 46.9 million in 2024, with a profit of RMB 12.7 million in the first eight months of 2025 [5][6]. Group 3: Shareholding Structure - The major shareholders include Wang Zhiyuan, who holds 39.1%, and Tencent, which is the largest institutional shareholder with nearly 20% ownership [5][7]. - The company has raised over USD 165 million through five rounds of financing since its establishment in 2012, with notable investors including Tencent and other prominent firms [5][6].